Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Super-SILAC mix for quantitative proteomics of human tumor tissue

Nature Methods volume 7, pages 383–385 (2010)Cite this article

Subjects

Abstract

We describe a method to accurately quantify human tumor proteomes by combining a mixture of five stable-isotope labeling by amino acids in cell culture (SILAC)-labeled cell lines with human carcinoma tissue. This generated hundreds of thousands of isotopically labeled peptides in appropriate amounts to serve as internal standards for mass spectrometry–based analysis. By decoupling the labeling from the measurement, this super-SILAC method broadens the scope of SILAC-based proteomics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Quantification of tumor tissue with one SILAC-labeled cell type versus super-SILAC mix.
Figure 2: Cancer-related proteins analyzed with the super-SILAC mix as internal standard.

Similar content being viewed by others

References

  1. Aebersold, R. & Mann, M. Nature 422, 198–207 (2003).

    Article  CAS  Google Scholar 

  2. Cravatt, B.F., Simon, G.M. & Yates, J.R. III. Nature 450, 991–1000 (2007).

    Article  CAS  Google Scholar 

  3. Bertucci, F., Birnbaum, D. & Goncalves, A. Mol. Cell. Proteomics 5, 1772–1786 (2006).

    Article  CAS  Google Scholar 

  4. Koomen, J.M. et al. Mol. Cell. Proteomics 7, 1780–1794 (2008).

    Article  CAS  Google Scholar 

  5. Ong, S.E. et al. Mol. Cell. Proteomics 1, 376–386 (2002).

    Article  CAS  Google Scholar 

  6. Ong, S.E. & Mann, M. Nat. Protocols 1, 2650–2680 (2006).

    Article  CAS  Google Scholar 

  7. Ishihama, Y. et al. Nat. Biotechnol. 23, 617–621 (2005).

    Article  CAS  Google Scholar 

  8. Pan, C., Kumar, C., Bohl, S., Klingmueller, U. & Mann, M. Mol. Cell. Proteomics 8, 443–450 (2009).

    Article  CAS  Google Scholar 

  9. Kruger, M. et al. Cell 134, 353–364 (2008).

    Article  Google Scholar 

  10. Wisniewski, J.R., Zougman, A., Nagaraj, N. & Mann, M. Nat. Methods 6, 359–362 (2009).

    Article  CAS  Google Scholar 

  11. Wisniewski, J.R., Zougman, A. & Mann, M. J. Proteome Res. 8, 5674–5678 (2009).

    Article  CAS  Google Scholar 

  12. Sekine, I., Shimizu, C., Nishio, K., Saijo, N. & Tamura, T. Int. J. Clin. Oncol. 14, 112–119 (2009).

    Article  CAS  Google Scholar 

  13. Avril, N. et al. J. Nucl. Med. 42, 9–16 (2001).

    CAS  PubMed  Google Scholar 

  14. Isidoro, A. et al. Carcinogenesis 26, 2095–2104 (2005).

    Article  CAS  Google Scholar 

  15. Gamallo, C. et al. Am. J. Pathol. 142, 987–993 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Rappsilber, J., Ishihama, Y. & Mann, M. Anal. Chem. 75, 663–670 (2003).

    Article  CAS  Google Scholar 

  17. Olsen, J.V. et al. Mol. Cell. Proteomics 4, 2010–2021 (2005).

    Article  CAS  Google Scholar 

  18. Cox, J. & Mann, M. Nat. Biotechnol. 26, 1367–1372 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank colleagues at the Department for Proteomics and Signal Transduction for assistance and fruitful discussion, and P. Ziolkowski (Department of Pathology, Wroclaw Medical University, Poland) for kindly providing us tumor tissues. T.G. is supported by a fellowship from the Humboldt Foundation. This work was partially funded by the European Commission's 7th Framework Program (grant agreement health-F4-2008-201648/PROSPECTS).

Author information

Authors and Affiliations

  1. Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Martinsried, Germany

    Tamar Geiger, Juergen Cox, Pawel Ostasiewicz, Jacek R Wisniewski & Matthias Mann

Authors
  1. Tamar Geiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juergen Cox
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pawel Ostasiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacek R Wisniewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matthias Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

T.G. designed and performed the experiments, analyzed the data and wrote the paper. J.C. developed analytical tools and assisted in data analysis. P.O. analyzed the tissue samples pathologically and assisted in data interpretation. J.R.W. developed experimental tools and provided tumor samples. M.M. conceived the super-SILAC idea, supervised the work and wrote the paper.

Corresponding author

Correspondence to Matthias Mann.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4, Supplementary Tables 1–6 (PDF 2394 kb)

Supplementary Table 7

Complete lists of identified proteins (XLS 5842 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geiger, T., Cox, J., Ostasiewicz, P. et al. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 7, 383–385 (2010). https://doi.org/10.1038/nmeth.1446

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.1446

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer